Brief: Lipocine Announces Positive Oral Brexanolone Quantitative EEG Results
10/10/2024 13:12
Oct 10 (Reuters) - Lipocine Inc LPCN.O :
* LIPOCINE ANNOUNCES POSITIVE ORAL BREXANOLONE QUANTITATIVE
EEG
RESULTS
* LIPOCINE INC - ORAL BREXANOLONE WELL-TOLERATED WITH
MINIMAL CNS
DEPRESSANT EFFECTS
Source text for Eikon: ID:nPn7tlCW4a
Further company coverage: LPCN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lipocine
See all newsUS STOCKS ON THE MOVE-Halozyme, Moderna, Merck
U.S. STOCKS ON THE MOVE-Halozyme, BKV, AppFolio
U.S. STOCKS ON THE MOVE-Hecla Mining, XPO, Lipocine
Lipocine surges after Canada approves co's testosterone replacement therapy
Brief: Lipocine Announces Health Canada Approval Of Tlando For Testosterone Replacement Therapy